The last CR only sucks in hindsight. What if Trof didn't get FDA approval, and we needed to raise more money for the NNZ-2591 trials? It was a prudent decision and simply a hedge.
Possibly a new direction?, page-22
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.53 |
Change
-0.070(0.45%) |
Mkt cap ! $1.995B | |||
| Open | High | Low | Value | Volume |
| $15.64 | $15.93 | $15.44 | $4.935M | 315.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | $15.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.53 | 7 | 1 |
View Market Depth
| Last trade - 14.34pm 15/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |